PREMIER
Precision Medicine in Rheumatology (PREMIER) is an NIH/NIAMS funded Center at UCSF with the overarching goal of facilitating and enhancing precision medicine studies in rheumatic diseases
PREMIER Funding Opportunities
Pilot funds available for junior (up to $40,000) and established investigators (up to $50,000)
Applications due: Monday 9/18/17, 2pm PDT
NEXT CYCLE- TBD
More information
HSCP Core
Human Subjects and Clinical Phenotyping Core provides expertise in study design, clinical informatics, and rheumatic diseases to facilitate the identification and recruitment of defined patient groups for research

CORE SERVICES
GMR Core
Genomics and Molecular Resources Core will provide access to biospecimens from rheumatic disease patients and facilitate access to state-of-the-art genomics and cellular molecular technologies
CORE SERVICES
IB Core
Integrative Bioinformatics Core will provide expertise in state-of-the-art computational approaches required for study design, bioinformatics data analysis, data integration, and data dissemination
CORE SERVICES

Mission 

PREMIER will provide investigators with access to biospecimens, expertise, training, and pilot funding to advance precision medicine studies in rheumatic diseases.

UCSF is a national leader in the area of precision medicine. PREMIER, Precision Medicine in Rheumatology is an NIH/NIAMS funded Center at UCSF with the overarching goal of facilitating and enhancing precision medicine studies in rheumatic diseases. The development of innovative technologies promises to deliver tests and therapies to patients that will enable us to tailor treatment and limit side effects, however for patients with rheumatic diseases, these studies are only in their infancy. PREMIER can provide investigators with resources to enable studies that will better define rheumatic disease subgroups with different etiologies, prognoses, or treatment responses. Core resources can provide access to clinical data and biospecimens along with new technologies for cellular, molecular and genetic phenotyping and bioinformatics analyses. PREMIER aims to improve approaches to the diagnosis and treatment of rheumatic disease. UCSF represents an ideal environment for the center given tremendous institutional strengths in immunology, genomics, molecular technologies, computational biology, and clinical research, and a track record of engaging both unique disease populations and racial/ethnic minority populations in clinical/translational research. PREMIER will work to attract both new and experienced investigators to investigations into human autoimmunity and support them to conduct breakthrough precision medicine studies focused on the rheumatic diseases. 

 

​

Dr. Raychaudhuri

Inaugural Seminar and Center Launch

Our keynote speaker, Dr. Soumya Raychaudhuri, Associate Professor at Brigham and Women's Hospital spoke on "The Genetics and Functional Genomics of Immune-Mediated Diseaes". Archived lecture is available here (MyAccess required). You can watch this video to also learn about our Center Cores and Services as well as upcoming funding opportunities.

 

96 well plates

 

Funding Opportunities  

PREMIER has several funding opportunities throughout the year, including pilot grants for established and junior investigators managed by the Resource Allocation Program (RAP), and Core Usage Grants managed by PREMIER. More details are available on the Funding Opportunities page of our website.